AntineoplasticsSevere myelosuppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1856卷 / 1期

关键词：

D O I：

10.1007/s40278-021-96065-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：72 / 72

相关论文

共 50 条

[1] AntineoplasticsSevere hypoproliferation and myelosuppression: case report
Reactions Weekly, 2023, 1955 (1) : 49 - 49
[2] AntineoplasticsSevere myelosuppression and lack of efficacy: case report
Reactions Weekly, 2024, 2027 (1) : 56 - 56
[3] AntineoplasticsSevere myelosuppression and acute encephalopathy: case report
Reactions Weekly, 2024, 2039 (1) : 64 - 64
[4] AntineoplasticsSevere mucositis and grade IV myelosuppression: case report
Reactions Weekly, 2016, 1601 (1) : 45 - 45
[5] AntineoplasticsSevere myelosuppression, agranulocytosis, femoral vein thrombosis and lack of efficacy: case report
Reactions Weekly, 2024, 2027 (1) : 57 - 57
[6] AntineoplasticsSevere infection: case report
Reactions Weekly, 2015, 1580 (1) : 39 - 39
[7] AntineoplasticsSevere gastrointestinal haemorrhage: case report
Reactions Weekly, 2018, 1691 (1) : 35 - 35
[8] AntineoplasticsSevere neutropenia and mucositis: case report
Reactions Weekly, 2020, 1829 (1) : 63 - 63
[9] AntineoplasticsSevere nephrotoxic effect: case report
Reactions Weekly, 2018, 1730 (1) : 41 - 41
[10] AntineoplasticsSevere neutropenia and infection: case report
Reactions Weekly, 2019, 1755 (1) : 37 - 37

← 1 2 3 4 5 →